696.64
-10.01 (-1.42%)
| Previous Close | 706.65 |
| Volume | 463,944 |
| Price / Earnings (Forward) | 41.59 |
| Price / Sales | 11.56 |
| Price / Book | 28.59 |
| 52 Weeks Range |
| Profit Margin | 22.76% |
| Operating Margin (TTM) | 31.70% |
| Diluted EPS (TTM) | 10.82 |
| Quarterly Revenue Growth (YOY) | 3.60% |
| Quarterly Earnings Growth (YOY) | 3.00% |
| Total Debt/Equity (MRQ) | 73.16% |
| Current Ratio (MRQ) | 1.16 |
| Operating Cash Flow (TTM) | 968.38 M |
| Levered Free Cash Flow (TTM) | 761.15 M |
| Return on Assets (TTM) | 22.98% |
| Return on Equity (TTM) | 59.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | IDEXX Laboratories, Inc. | Mixed | Bullish |
AIStockmoo Score
| Value 35% | -2.3 |
| AI Insight info | NA |
| Relative Valuation info | -5.0 |
| Financial Health info | 1.8 |
| Timing 35% | 3.0 |
| AI Technical info | NA |
| Technical Oscillators info | 4.0 |
| Technical Moving Averages info | 1.5 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×0.95 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | +34.5% |
| Pillar Agreement | ×0.82 |
| Not in score | |
| Price Volatility info | -2.6 |
| Final Score | 0.20 |
Select this tab to load the latest available analysis.
|
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Growth |
| % Held by Insiders | 0.67% |
| % Held by Institutions | 97.51% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |